COLLEEN FITZPATRICK: Open Payments
NPI 1801527429 · EAST SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$454 in 25 payments from 16 companies in 2025. Trend: 2023 $71 · 2024 $645 · 2025 $454
Food & beverage: $454
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $58 |
| Novo Nordisk Inc | 3 | $52 |
| Amgen Inc. | 3 | $45 |
| Biogen, Inc. | 2 | $40 |
| Madrigal Pharmaceuticals | 1 | $35 |
| Boston Scientific Corporation | 1 | $35 |
| ABBVIE INC. | 2 | $29 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Corcept Therapeutics | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: CAPLYTA, OTEZLA, ZURZUVAE, REZDIFFRA, WATCHMAN, Wegovy, Auvelity, Korlym.
Industry payments across NY — which companies pay providers there.
